HER-2/neu is a transmembrane growth factor receptor, the overexpression of which is recognized as an independent adverse prognostic factor in several cancers, including pancreatic cancer [18], [19], [20], [21], [22], [23], [24], [25]. This evidence concerns the gene ERBB2 and familial pancreatic carcinoma.